Publications
- Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University
- Candidate MicroRNA biomarkers of therapeutic response to sunitinib in metastatic renal cell carcinoma: A validation study in patients with extremely good and poor response2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer2017 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Dual targeted therapy in patients with malignant melanoma2017 | Faculty of Medicine in Hradec Králové
- Rapid and clinically significant response to masitinib in the treatment of mucosal primary esophageal melanoma with somatic KIT exon 11 mutation involving brain metastases: A case report2015 | Faculty of Medicine in Hradec Králové
- Adverse Effects of Modern Treatment of Malignant Melanoma and their Treatment/Management2014 | Faculty of Medicine in Hradec Králové
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
- Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
Loading network view...